Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Supernus Pharmaceuticals - 12 Year Stock Split History | SUPN

Stock split history for Supernus Pharmaceuticals since 2012. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Supernus Pharmaceuticals Annual Stock Splits
Supernus Pharmaceuticals Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.587B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.776B 5.34
Dr Reddy's Laboratories (RDY) India $11.900B 18.82
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.164B 2.47
Amphastar Pharmaceuticals (AMPH) United States $1.957B 13.40
Taysha Gene Therapies (TSHA) United States $0.458B 0.00
Generation Bio (GBIO) United States $0.198B 0.00
Assembly Biosciences (ASMB) United States $0.071B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.030B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00